NAMSW icon

NewAmsterdam Pharma Company N.V. Warrant

18 hedge funds and large institutions have $3.49M invested in NewAmsterdam Pharma Company N.V. Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
18
Holders Change
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
1
Calls
$143K
Puts
Net Calls
+$143K
Net Calls Change
-$14K
Name Market Value Shares Shares
Change
Shares
Change %
FLSM
1
Frazier Life Sciences Management
California
$951K 500,333
RCM
2
RA Capital Management
Massachusetts
$633K 333,333
EC
3
EcoR1 Capital
California
$617K 66,665
AAA
4
Affinity Asset Advisors
New York
$260K 137,000 +100,000 +270%
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$255K 150,000
BCLSI
6
Bain Capital Life Sciences Investors
Massachusetts
$190K 100,000
DM
7
Deerfield Management
New York
$176K 92,787
HCM
8
Highbridge Capital Management
New York
HF
9
HRT Financial
New York
$57K 30,321
WCMNY
10
Westchester Capital Management (New York)
New York
$54.6K 31,189
Walleye Capital
11
Walleye Capital
New York
$43.1K 22,658 -9,600 -30%
PI
12
PEAK6 Investments
Illinois
$32.3K 17,000
LCM
13
Laurion Capital Management
New York
$31.7K 16,666
CS
14
Clear Street
New York
$25.6K 13,463
Walleye Trading
15
Walleye Trading
New York
$24.9K 13,084 -5,400 -29%
ETH
16
Exos TFP Holdings
New York
$23.3K 12,273 -10,000 -45%
VI
17
Vestcor Inc
New Brunswick, Canada
$18K 9,632
CG
18
Cutler Group
California
$9K 4,960
UBS Group
19
UBS Group
Switzerland
$72 38 +38 New
WAM
20
Wolverine Asset Management
Illinois
-12,448 Closed
CFGS
21
Concourse Financial Group Securities
Alabama
Millennium Management
22
Millennium Management
New York